Key result
TLR4 deficiency significantly improved left ventricular ejection fraction (46.53% vs 26.94%) and reduced infarct size (14% vs 22%) following myocardial ischemia and reperfusion in mice.
Why the study?
Does TLR4 deficiency reduce inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium following regional ischemia/reperfusion in mice?
Does TLR4 deficiency reduce inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium following regional ischemia/reperfusion in mice?
Absolute Event Rate: 46.53% vs 26.94%
p-value: p=<0.05
TLR4 deficiency attenuates inflammatory responses and matrix remodeling in remote non-ischemic myocardium, leading to improved left ventricular function after ischemia/reperfusion injury.
Should not change clinical practice; leaves open TLR4 targeting for human ischemia/reperfusion injury.
UNLABELLED: The signaling mechanism that mediates inflammatory responses in remote non-ischemic myocardium following regional ischemia/reperfusion (I/R) remains incompletely understood. Myocardial Toll-like receptor 4 (TLR4) can be activated by multiple proteins released from injured cells and plays a role in myocardial inflammation and injury expansion. We tested the hypothesis that TLR4 occupies an important role in mediating the inflammatory responses and matrix protein remodeling in the remote non-ischemic myocardium following regional I/R injury. METHODS AND RESULTS: TLR4-defective (C3H/HeJ) and TLR4-competent (C3H/HeN) mice were subjected to coronary artery ligation (30 min) and reperfusion for 1, 3, 7 or 14 days. In TLR4-competent mice, levels of monocyte chemoattractant protein -1 (MCP-1), keratinocyte chemoattractant (KC), intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) were elevated in the remote non-ischemic myocardium at day 1, 3, and 7 of reperfusion. Levels of collagen I, collagen IV, matrix metalloproteinase (MMP) 2 and MMP 9 were increased in the remote non-ischemic myocardium at day 7 and 14 of reperfusion. MMP 2 and MMP 9 activities were also increased. TLR4 deficiency resulted in a moderate reduction in myocardial infarct size. However, it markedly downgraded the changes in the levels of chemokines, adhesion molecules and matrix proteins in the remote non-ischemic myocardium. Further, left ventricular function at day 14 was significantly improved in TLR4-defective mice. In conclusion, TLR4 mediates the inflammatory responses and matrix protein remodeling in the remote non-ischemic myocardium following regional myocardial I/R injury and contributes to the mechanism of adverse cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2015) studied Myocardial ischemia and reperfusion injury. TLR4 deficiency vs. TLR4-competent mice was evaluated on Left ventricular ejection fraction at day 14 (p=<0.05). TLR4 deficiency significantly improved left ventricular ejection fraction (46.53% vs 26.94%) and reduced infarct size (14% vs 22%) following myocardial ischemia and reperfusion in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: